|
|
Priapism secondary to chronic myeloid leukemia treated by a surgical cavernosa-corpus spongiosum shunt: Case report |
Min Qu,Xin Lu,Lei Wang,Zhiyong Liu,Yinghao Sun(),Xu Gao()
|
Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China |
|
|
Abstract Priapism secondary to chronic myeloid leukemia (CML) is rarely observed in the clinic. Here, we present an 18-year-old patient with priapism for over 72 h due to hyperleukocytosis. Emergent interventions such as therapeutic aspiration and intracorporal injection of phenylephrine failed before a surgical corpora cavernosa-corpus spongiosum shunt was inserted to relieve symptoms. During hospitalization, bone marrow aspiration confirmed the diagnosis of CML.
|
Received: 24 March 2018
Available online: 15 December 2018
|
Corresponding Authors:
Yinghao Sun,Xu Gao
E-mail: sunyh@medmail.com.cn;gaoxu.changhai@foxmail.com
|
|
|
|
The clinical situation of the patient in the hospital. (A) Pathological erectile penis of the patient; (B) Flaccid penis after surgery; (C) Swelling scrotum due to compression of blood clots.
|
Study | Number of cases | Age (year) | White blood cell count (×109/L) | Treatment | Result | Kurosawa et al. [7], 2016 | 4 | NA | NA | 3 for therapeutic aspiration, 1 for leukapheresis | 2 with erectile dysfunction | Nerli et al. [8], 2016 | 1 | 19 | 296.8 | Corporal aspiration and phenylephrine irrigation | No follow-up | Ergenc et al. [4], 2015 | 1 | 18 | 100 | Leukapheresis | No erectile dysfunction | Shaeer et al. [9], 2015 | 1 | 21 | 410 | Initiated by cavernosal aspiration/irrigation and injection of epinephrine, followed by penileprosthesis surgery | Erectile dysfunction followed by penile prosthesis implantatio | Hazra et al. [10], 2013 | 1 | 14 | 226.9 | Cavernosal aspiration, irrigation and phenylepinephrine injection | Maintaining erection | Veljkovic et al. [11], 2012 | 1 | 16 | 320 | Leukapheresis | No follow-up | Tazl [12], 2009 | 1 | 33 | 400 | Cavernosa aspiration and epinephrine irrigation | No erectile dysfunction | Gupta et al. [13], 2009 | 1 | 12 | 346 | Administration of terbutaline | No follow-up |
|
Case reports of priapism secondary to chronic myeloid leukemiain in recent 10 years.
|
[1] |
Van der Horst C, Stuebinger H, Seif C, Melchior D, Martinez- Portillo FJ, Juenemann KP . Priapismdetiology, pathophysiology and management. Int Braz J Urol 2003; 29:391-400.
|
[2] |
Burnett AL, Bivalacqua TJ . Priapism: new concepts in medical and surgical management. Urol Clin North Am 2011; 38:185-94.
|
[3] |
Diallo D, Zaitouna M, Alsaid B, Quillard J, Droupy S, Benoit G . What is the origin of the arterial vascularization of the corpora cavernosa? A computer-assisted anatomic dissection study. J Anat 2013; 223:489-94.
|
[4] |
Ergenc H, Varim C, Karacaer C, Cekdemir D . Chronic myeloid leukemia presented with priapism: effective management with prompt leukapheresis. Niger J Clin Pract 2015; 18:828-30.
|
[5] |
Rodgers R, Latif Z, Copland M . How I manage priapism in chronic myeloid leukaemia patients. Br J Haematol 2012; 158:155-64.
|
[6] |
Kandel GL, Bender LI, Grove JS . Pulmonary embolism: a complication of corpus-saphenous shunt forpriapism. J Urol 1968; 99:196-7.
|
[7] |
Kurosawa H, Tanizawa A, Tono C, Watanabe A, Shima H, Ito M , et al. Leukostasis in children and adolescents with chronic myeloid leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatr Blood Cancer 2016; 63:406-11.
|
[8] |
Nerli RB, Magdum PV, Hiremath SC, Patil AY, Pai SV, Handigund RS , et al. Priapismda rare presentation in chronic myeloid leukemia: Case report. Urol Case Rep 2016; 4:8-10.
|
[9] |
Shaeer OK, Shaeer KZ, AbdelRahman IF, El-Haddad MS, Selim OM . Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature. J Sex Med 2015; 12:827-34.
|
[10] |
Hazra SP, Priyadarshi V, Gogoi D, Sharma PK, Pal DK, Chakraborty SC . Pediatric priapism: a rare first manifestation of leukemia. APSP J Case Rep 2013; 4:39.
|
[11] |
Veljkovic D, Kuzmanovic M, Micic D, ?erbi?-Nonkovi? O . Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. Transfus Apher Sci 2012; 46:263-7.
|
[12] |
Tazi I . Priapism as the first manifestation of chronic myeloid leukemia. Ann Saudi Med 2009; 29:412.
|
[13] |
Gupta A, Seth T, Gupta A . Successful use of terbutaline in persistent priapism in a12-year-old boy with chronic myeloid leukemia. Pediatr Hematol Oncol 2009; 26:70-3.
|
No related articles found! |
|
|
|
|